Of these IC, the most studied are IDO, PD-1, and CTLA-4 that are implicated in the progression of glioma and glioblastoma [97] and, for this reason, have been considered as potential targets for immunotherapy. This evidence concerns the gene IDO1 and central nervous system cancer.